Obtained More than $40 Million in Settlements for Victims of Alleged Blood Reagents Price-Fixing Conspiracy

October 25, 2018

In re: Blood Reagents Antitrust Litigation, 09-md-02081 (E.D. Penn.)

Robins Kaplan served on the executive committee in this class action, which alleged that defendants Ortho Clinical Diagnostics, Inc., a former Johnson & Johnson subsidiary, colluded with Immucor, Inc. to raise prices on traditional blood reagents, which are used to test blood before transfusions and donations. Aggregate settlements totaled more than $40 million and the case concluded in October 2018. Notably, the Department of Justice had initially opened a criminal investigation into defendants’ practices, but subsequently closed the investigation without taking any action.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer

Related Practices

Antitrust and Trade Regulation

Similar Results

Achieved Extraordinary $5.5 Billion Settlement in Interchange Fee and Merchant Discount Litigation
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Reached Global, Cost-of-Defense Settlements for Norwegian Salmon Distributor and Producer in Nationwide Antitrust Class Action
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Reached Settlements in Excess of $118 Million in Disposable Contact Lens Antitrust Litigation
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Reached Settlement in Antitrust Class Action Relating to Precious Metals Futures Contracts Trading
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Reached Settlement Worth Up to $28 Million Against Martin Shkreli and His Former Companies for Alleged Monopolization of Life-Saving Drug Daraprim
Antitrust and Trade Regulation Business Litigation Class Action Litigation Health Care Litigation
$19.5 Million Settlement Secured for Indirect Buyers in Interior Molded Doors Antitrust Litigation
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Secured $7.2 Million Settlement for Plaintiff Alleging Monopolization of Oncology Services in Southwest Florida
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Defended Supervalu in Extensive Antitrust Class Action Litigation
Antitrust and Trade Regulation Appellate Advocacy and Guidance Business Litigation Class Action Litigation
Secured Settlement of $432 Million in Class Action Against Wells Fargo
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Secured $76.8 Million Verdict on Behalf of Health Insurers in Direct Action Alleging Unlawful Monopolization of Prescription Drugs
Antitrust and Trade Regulation Business Litigation Direct Actions and Opt-Out Practice
Secured a $22.5 Million Jury Verdict and More Than $400 Million in Settlements on Behalf of Best Buy in Direct Action Alleging Price-Fixing of LCD Displays
Antitrust and Trade Regulation Business Litigation Direct Actions and Opt-Out Practice
Secured in Excess of $1.2 Billion in Settlements in Air Cargo Shipping Services Antitrust Litigation
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Obtained Full Dismissal for Graco in Putative Nationwide Antitrust Class Action
Antitrust and Trade Regulation Appellate Advocacy and Guidance Business Litigation Class Action Litigation
Obtained Nearly $600 Million in Settlements in Class Action Against Private Equity Firms
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Obtained Full Dismissal for Carlson Hotels, Inc. and Radisson Hotels International, Inc. in Antitrust Lawsuit
Business Litigation Antitrust and Trade Regulation
Back to Top